KFF Health News lists red flags for patients buying peptides
The consumer-facing piece addresses marketing claims around peptide therapy as gray-market sales expand.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 19 05:02 ETSource: KFF Health News
The wire
- 01KFF Health News published a guide framed around four red flags and one truth in the current peptide marketplace.
- 02Clinicians and pharmacists field patient questions driven by this kind of coverage, which shapes expectations about unapproved peptide products.
- 03The item is explanatory rather than a report of new regulatory or clinical action.
From the source
Read at kffhealthnews.orgFour Red Flags and One Truth Amid the Peptide Hype
